Company
JapanTOYO Pharmaceutical Co., Ltd., Osaka, Japan – FDA Inspections
Inspection records and compliance data for TOYO Pharmaceutical Co., Ltd. in Osaka. 2 FDA inspections on record, 2 Form 483s, last inspected June 12, 2026.
Company Profile
This profile covers TOYO Pharmaceutical Co., Ltd. based in Osaka, Japan.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected June 16, 2023. Last inspected June 12, 2026.
Most cited issue areas
- Annual visual exams of drug products1 inspection
- Computer control of master formula records1 inspection
- Drug product reserve containers1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 12, 2026 | Not classified | Human Drugs · Drug Quality Assurance | 1322480 |
| June 16, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1208748 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
TOYO Pharmaceutical Co., Ltd.
FEI Number
3016419927
Address
2 Chome 5-4, Tsurumi; Tsurumi, Osaka, Japan
Country
Japan
ID: 21837e65-0d4e-4e06-becd-fd959cccc990